Spectrophotometric method of estimation of atorvastatin calcium using sulfo-phospho-vanillin reaction

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 6, 2012, Pages 150-154

  Bernard, Shyni ^a   Mathew, Molly ^a  

^a Malik Deenar College of Pharmacy   (India)

Author keywords

Atorvastatin; Spectrophotometry; Tablets; Vanillin

Indexed keywords

EID: 84876059525     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2606     Document Type: Article

References (16)

1. Altuntas T G., Erk N. Liquid chromatographic determination of Atorvastatin in bulk drugs, tablets and human plasma .J. Liq. Chro.2004; 27 (1): 83
2. Black A E., Sinz M W., Hayes R N., and Woolf T F. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxyl-3- methyl glutaryl- CoA reductase inhibitor atorvastatin ; Drug Metab. Dispos.1998 ; 26: 755.
3. th ed.(September 2007) Section: 2.12.
4. Bullen W W., Miller R A., Hayes R N.Development and validation of a high performance liquid chromatography tandem mass spectrometry assay for atorvastatin, orthohydroxy atorvastatin and parahydrxy Atorvastatin in human, dog and rat plasma; Amer. Soc. Mass Spectrum.1999; 10: 55.
5. Chabrol E., and Charonnat R. Une nouvele reaction pour l'etudes des lipides: L'oleidemie. Presse Med.1937; 45:1713.
6. Christopher S Frings., Ted W Fendley., Ralph T Dunn., and Cecelia A Queen. Improved determination of total serum lipids by the Sulfo-Phospho-Vanillin Reaction.Clinical Chemistry.1972;18 (7):673.
7. Curtis,Sutter,Walkar & Hoffmann (2002) Integrated Pharmacology (2nd edn). ( p-30) Mosby International,Ltd.
8. Frings C S., Dunn R T. A colorimetric method for determination of total serum lipids based on the sulfo-phosphovanihin reaction. Amer. J. Clin. Pathol.1970; 53:89).
9. Gowari Sankar D., Raju M S M., Sumanth., Kalyan S., Latha P V M. Estimation of Atorvastatin by high performance liquid chromatography in pure and pharmaceutical dosage form. Asian J. Chem.2005; 17 (4) : 2571.
10. ICH Q2B, Text on Validation of Analytical Procedures. Geneva (1994) 1-5.
11. McKenney J M., Mccormik L S., Weis S., Koren M., Kotonek S., Black D M. A Randomized Trial of the Effects of Atorvastatin and Niacin in Patients with Combined Hyperlipidemia or Isolated Hypertriglyceridemia.Amer. J. Med.1998; 104: 137.
12. rd edn) Part 2(p 654) The Pharmaceutical Press: Great Britain.
13. Morrison, R. T., and Boyd, R. N.,(1968).Organic Chemistry(2nd edn). Boston, Mass (p.161) Allyn & Bacon, Inc.
14. Poswar E L., Radulovic L L., Cilla D D., Whitfield L R., Sedman A J.Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects. J. Clin. Pharmacol.1996 ; 36: 728.
15. Yadav S S., Mhaske D V., Kakad A B., Patil B D., Kadam S S., Dhaneshwar SR. A simple and sensitive HPTLC method for the determination of content uniformity of Atorvastatin calcium tablets. Indian J. Pharm. Sci.2005; 67(2): 182.
16. Zoeliner N., Kirsch K., Uber die.Quantitative Bestimmung von Lipoiden mittels der vielen naturlischen Lipoiden gemeinsamen sulfophosphovanillin Reaction. Z. Gesamte Exp. Med.1962; 135 : 545.